TY - JOUR T1 - ABC of Endometriosis Surgery: Aqua Blue Contrast Technique JF - medRxiv DO - 10.1101/2020.02.27.20027888 SP - 2020.02.27.20027888 AU - Tamer Seckin AU - Bahar Yuksel AU - Serin Seckin AU - Ayse Ayhan Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/02/29/2020.02.27.20027888.abstract N2 - Objective Peritoneal endometriosis is the most prevalent yet least diagnosed type due to its unrecognizable nature on imaging modalities especially non- pigmented lesions would escape the surgeons’ eye and experience during diagnostic laparoscopy. We used color adjuvant by the technique called Aqua Blue Contrast Technique (ABCT) to optimize the view and to improve results.Material methods Patient charts who undergone surgery from 2014 to 2015 and their 5 year follow up data, along with two different control groups, have been analyzed retrospectively. As the first group the patients who had conventional surgery without the use of ABCT) were included, the second group were patients who had ABCT applied on both pelvic side walls but not in cul-de-sac and as the third group the patients who had the surgery with the use of ABCT in all peritoneal cavity have been analyzed. Cases involving ovarian endometriomas and DIE were excluded.Results All patients have been followed up for up to 5 years. In group 1, the recurrence within the postoperative 3 years was 11.9%, and 16.1% after 5 years of surgery. The recurrence of 3 years period and 5 years period for the patients in group 2 were 8.7& and 12.1% respectively. The patients in group 3 recurred 3.2% in the 3 years period and the 4.3% recurrence rate calculated as 4.5% for the following 5 years after surgery.Conclusion Results indicate elimination of high-end spectrum of light using aqua blue contrast technique with hydrodistension of the retroperitoneum enhances the surgeon’s vision, allows lesions otherwise not detected with white light.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNA..RETROSPECTIVE STUDYFunding StatementThere is no financial conflict of interest or any funding received for the study.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesdata is available in case of requested ER -